Navigation Links
The Quigley Corporation Reports First Quarter 2009 Results
Date:5/1/2009

rvations obtained from the study relate to positive effect on nerve functioning, the Company may, in the future, be focusing on a broader therapeutic area.

The World Health Organization estimates, more than 171 million people have diabetes worldwide. It is also estimated that 20 million people, representing approximately 7% of the United States population have diabetes of which some 60% will suffer from mild to severe nerve damage due to Diabetic Peripheral Neuropathy. Conditions associated with Diabetic Peripheral Neuropathy include numbness, skin ulcers, constant pain or extreme sensitivity to stimulus.

The Quigley Corporation makes no representation that the US Food and Drug Administration or any other regulatory agency will allow this Investigational New Drug to be marketed. Furthermore, no claim is made that potential medicine discussed herein is safe, effective, or approved by the Food and Drug Administration.

Additionally, data that demonstrates activity or effectiveness in animals or in vitro tests do not necessarily mean the formula test compound; referenced herein will be effective in humans. Safety and effectiveness in humans will have to be demonstrated by means of adequate and well-controlled clinical studies before the clinical significance of the formula test compound is known. Readers should carefully review the risk factors described in filings the Company files from time to time with the Securities and Exchange Commission.

About The Quigley Corporation

The Quigley Corporation (Nasdaq: QGLY, http://www.Quigleyco.com) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufactur
'/>"/>

SOURCE The Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification
2. The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
3. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
4. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
5. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
6. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
7. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
8. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
9. Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes
10. Protein Sciences Corporation Appoints New Board of Directors
11. Digirad Corporation Reports First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Insuranceragents.info has released a new blog post ... for vulnerable family members. , Life insurance plans provide ... the family should always carry a life insurance policy ... rest of the family. , Clients can choose ... from temporary coverage or from a permanent policy. No ...
(Date:10/1/2014)... and ATLANTA (PRWEB) October 01, 2014 ... security executive networking and relationship-marketing firm, announced ... Information Security Executive® and Project of the ... top-ranking decision makers representing organizations in financial ... Projects include large-scale technology endeavors that address ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... 01, 2014 Scientists at the University ... that target immune system proteins has the power to ... posted details of the new study on their website. ... , Researchers in the UWA School of Pathology and ... to mice with mesothelioma with promising results. , ...
(Date:10/1/2014)... 01, 2014 Woodland Hills dental ... a group of dental specialists who treat full mouth ... city of Oviedo. Dr. Reshad of the Anacapa Dental ... clients on two continents, will give a full-day presentation ... mouth reconstruction. , “These specialists want to improve their ...
Breaking Medicine News(10 mins):Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4
... that often deals with changes over many generations have ... A lot, some scientists say. If recent recommendations are implemented, ... entrance and licensing exams, says an international group of doctors ... 26 issue of Proceedings of the National Academy of ...
... is the focus of a $1.27-million grant from the ... researchers working with employees from six Pennsylvania prisons and ... an intervention toolkit for use by staff at any ... to optimize the quality of life for dying patients ...
... Vancouver’s ... meet Matt Lauer when he is in Vancouver to shoot the Today Show during the ... (PRWEB) ... is on a mission to meet Matt Lauer when he is in Vancouver to shoot ...
... , ... Spend More Time Indoors Increasing Owners Exposure to Allergens Like Pet Dander. earthbath’s Totally Natural ... , ... 26, 2010 -- Everyone wants to be inside when winter’s chilly winds blow, and Fido ...
... ... for physicians, including current and future adoption of electronic medical records, e-prescribing, ... ... are the physician specialist groups most likely to communicate with patients online, according ...
... SEATTLE , Jan. 26 Milliman Care Guidelines ... tools that help health plans, hospitals and other clients optimize ... and software.   , The Care Guidelines promote ... based on annually updated evidence, thus enabling informed and consistent ...
Cached Medicine News:Health News:Medical students may soon be tested on evolution 2Health News:Medical students may soon be tested on evolution 3Health News:End-of-life care strategies examined in Pennsylvania prisons 2Health News:Vancouver Company Must Meet Matt Lauer During Olympics 2Health News:Control Winter Pet Dander with earthbath's New Waterless Grooming Foam for Dogs 2Health News:Control Winter Pet Dander with earthbath's New Waterless Grooming Foam for Dogs 3Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 2Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 3Health News:Dermatologists, Medical Oncologists are the Top Physician Specialist Groups Communicating with Patients Online 4Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 2Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 3Health News:Milliman Care Guidelines Offers Online Interrater Reliability Tool and Training 4
(Date:10/1/2014)... , Oct. 1, 2014  SI-BONE, Inc., a medical ... System, ® a minimally invasive surgical (MIS) device indicated ... today announced the expansion of its European operations with the ... Eric Schaber as General Manager, Germany.  Mr. Schaber will ... president of Europe , Middle ...
(Date:9/30/2014)... 30, 2014 /CNW/ - Protecting the health and safety of Canadians ... uses the appropriate powers and tools at its disposal to help ... quality standards. To that end, Health ... import into Canada of all drug products ... are: , Apotex Pharmachem India Pvt Ltd ...
(Date:9/30/2014)... Md. , Sept. 30, 2014  Tasly ... way to modernize medicine, announced today the launch ... of nutraceuticals developed to address men and women ... healthy and vibrant into old age while helping ... includes three condition-specific, whole-food and herb-based formulas, namely, ...
Breaking Medicine Technology:SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 2SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 3SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 4Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2
... 17 An optimized PARI eFlow,platform nebulizer will ... clinical trial that has begun enrolling patients. ALN-RSV01 ... for respiratory syncytial virus,(RSV) infection, the leading cause ... infection in immune-compromised adults. RSV currently does,not have ...
... 17 AlphaVax, Inc.,announced today an initial analysis ... a cytomegalovirus (CMV) vaccine that is based on ... is a placebo-controlled, randomized, double-blind, single,center study involving ... is being conducted by David I. Bernstein, M.D., ...
Cached Medicine Technology:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study 2AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial 2AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: